Vision Clinical Trials
Here are the 6 most popular medical studies for vision
Cell Therapy
NT-501 ECT for Glaucoma
This trial is testing a new eye surgery for people with glaucoma. The surgery will either be the new treatment or a fake surgery, and no one will know which they got. There will be follow-up appointments to check safety and to see if the new treatment works better than the fake surgery.
Behavioral Intervention
Reflective Supervision for Emotion Regulation
This trial tests an enhanced early care & education program to improve supervisor & teacher interactions, teaching quality and child social-emotional development. Researchers compare outcomes in participants receiving the program vs. those in a control group.
Side Effect Monitoring of VEGF-Inhibitors in Renal Cell Carcinoma
This trial explores how collecting patient data directly can help manage side effects of oral chemo for mRCC. Patients will complete weekly surveys and be contacted when symptoms worsen. Through this trial, researchers hope to improve patient care.
Popular filter options for vision trials
Age-Related Macular Degeneration Clinical Trials
View 6 Age-Related Macular Degeneration medical studies.
Low Vision Aid System
Low Vision Aid System for Age-Related Macular Degeneration
“ I am told that there is no treatment for AMD and I am looking to be accepted for a clinical trial which is focused on treatment. I am looking to take preventative steps.”
Stem Cell Therapy
ASP7317 for Age-related Macular Degeneration
This trial is for adults 50+ who are losing their vision due to dry age-related macular degeneration. A new treatment, ASP7317, which is a specially created type of cell derived from human stem cells, will be injected into the macula of the eye in an effort to slow or reverse atrophy.
VEGF Inhibitor
Aflibercept for Age-Related Macular Degeneration
“ I had an eye exam and was told I have beginnings of macular disease. My mother and aunt both loss their eyesight. I am hoping to help myself and others avoid blindness.”
Brain Stimulation
Active tDCS for Age-Related Macular Degeneration
This trial is testing whether a-tDCS, a kind of brain stimulation, can be combined with perceptual learning to improve the ability of people with age-related or juvenile macular degeneration to read words on a computer screen.
AMD Clinical Trials
View 6 AMD medical studies.
Low Vision Aid System
Low Vision Aid System for Age-Related Macular Degeneration
“ I am told that there is no treatment for AMD and I am looking to be accepted for a clinical trial which is focused on treatment. I am looking to take preventative steps.”
Stem Cell Therapy
ASP7317 for Age-related Macular Degeneration
This trial is for adults 50+ who are losing their vision due to dry age-related macular degeneration. A new treatment, ASP7317, which is a specially created type of cell derived from human stem cells, will be injected into the macula of the eye in an effort to slow or reverse atrophy.
VEGF Inhibitor
Aflibercept for Age-Related Macular Degeneration
“ I had an eye exam and was told I have beginnings of macular disease. My mother and aunt both loss their eyesight. I am hoping to help myself and others avoid blindness.”
Brain Stimulation
Active tDCS for Age-Related Macular Degeneration
This trial is testing whether a-tDCS, a kind of brain stimulation, can be combined with perceptual learning to improve the ability of people with age-related or juvenile macular degeneration to read words on a computer screen.
Phase 3 Vision Clinical Trials
View 90 phase 3 vision medical studies.
VEGF Inhibitor
Aflibercept for Age-Related Macular Degeneration
“ I had an eye exam and was told I have beginnings of macular disease. My mother and aunt both loss their eyesight. I am hoping to help myself and others avoid blindness.”
Corneal Inlay
Raindrop Near Vision Inlay for Presbyopia
The objective of this study is to evaluate the safety and effectiveness of the Raindrop Near Vision Inlay implanted in bilateral pseudophakes with presbyopia for improvement of near and intermediate vision.
Behavioural Intervention
Office-based vergence/accommodative therapy for Convergence Insufficiency
CITT-ART is a multicenter study (8 locations around the United States) of 324 children ages 9 to <14 years with symptomatic convergence insufficiency (CI). The purpose of this study is to see if office-based therapy for convergence insufficiency (CI) improves reading ability and attention. CI is an eye-teaming problem where the eyes would like to drift outward when reading or doing close work. When eyes drift out, double vision can happen. To prevent double vision one must use extra effort to keep the eyes from going out. This extra effort can cause symptoms that can interfere with reading and working comfortably at near. These symptoms often include eyestrain, blurred vision, headaches, double vision, and loss of place when reading or performing tasks at near. In a prior study we found that therapy improves these symptoms. In this study we are looking at whether the therapy improves reading and attention
Vision Clinical Trials With No Placebo
View 90 vision medical studies that do not have a placebo group.
Procedure
Axoguard HA+ Nerve Protector™ for Cubital Tunnel Syndrome
This trial will test how well Axoguard HA+ Nerve Protector can protect a nerve during a cubital tunnel operation. It'll measure pain, motor/sensory outcomes, QoL, & more to see if it's successful.
Procedure
Visual Prosthesis for Blindness
This trial is to create a Smart Bionic Eye to help those with visual impairments navigate the world and improve their quality of life. It would use AI-powered scene understanding to recognize faces, read, and help with outdoor navigation.
Behavioural Intervention
Stroboscopic Vision Training for Vision Impairment and Sports Performance
This trial is testing if stroboscopic vision goggles, which flicker to remove visual information for a brief moment, can enhance visual performance during a softball season for high school girls.
Low Vision Aid System
Low Vision Aid System for Age-Related Macular Degeneration
“ I am told that there is no treatment for AMD and I am looking to be accepted for a clinical trial which is focused on treatment. I am looking to take preventative steps.”
View More Vision Trials
See another 65 many medical studies focused on vision.
Frequently Asked Questions
Introduction to vision
What are the top hospitals conducting vision research?
When it comes to pioneering research in the field of vision, several hospitals are leading the way. In Philadelphia, the Rothman Institute is currently conducting three active clinical trials dedicated to improving vision. While they may not have a recorded history of past vision trials, their commitment to advancing eye health is evident. Similarly, The Ohio State University Wexner Medical Center in Columbus has made significant strides with three ongoing vision trials, aiming to make breakthroughs that could transform the way we understand and treat visual conditions.
Heading over to Californiae Ohio State University Wexner Medical Center in Columbus has made significant strides with three ongoing vision trials, aiming to make breakthroughs that could transform the way we understand and treat visual conditions.
Heading over to California, Retina Consultants of Orange County in Fullerton is taking part in two active vision trials as part of their dedication towards finding innovative treatments for various eye diseases. Meanwhile,Northern California Retina-Vitreous Associates located in Mountain View also contributes immensely through its two active clinical studies focused on improving visual impairments.
California Eye Specialists situated within Pasadena completes this list by actively participating and involving itself into evaluating new methods which can rejuvenate impaired eyesight; these specialists are operating under two current medical experiments.
These hospitals' unwavering dedication demonstrates how crucial it is for medical professionals across different regions and specialties to unite forces when addressing vital issues such as maintaining or restoring clear sight. By collaborating on cutting-edge research initiatives like these, experts worldwide strive toward enhancing our understanding of ocular disorders while continuously pushing boundaries for improved treatment options that empower individuals experiencing visual challenges today - and potentially transforming lives tomorrow
Which are the best cities for vision clinical trials?
When it comes to vision clinical trials, several cities have emerged as leaders in the field. Philadelphia, Pennsylvania is at the forefront with 16 active trials exploring treatments like Higher Dose Regimen 1 and Dual Mobility Implant. Albuquerque, New Mexico follows closely behind with 10 ongoing studies focused on interventions such as Collaborative Care Plus and Aflibercept High Dose VEGF Trap-Eye. Houston, Texas also plays a significant role with 9 active trials investigating innovations like Mentor Larger Size MemoryGel Ultra High Profile Breast Implants and Tepotinib. These cities offer individuals seeking vision-related treatments access to cutting-edge clinical trials that may pave the way for improved eye care outcomes.
Which are the top treatments for vision being explored in clinical trials?
Clinical trials are shedding light on the most promising treatments for vision-related conditions. Among them, three standout options have been capturing attention and showing potential in ongoing research:
- Gene therapy: With its ability to target specific genetic mutations responsible for vision loss, gene therapy holds promise as a groundbreaking treatment.
- Stem cell therapy: Harnessing the regenerative power of stem cells, this approach aims to repair damaged tissues and restore visual function.
- Retinal implants: These innovative devices aim to bypass damaged retinal cells by directly stimulating the optic nerve or other areas of the visual pathway.
What are the most recent clinical trials for vision?
Exciting developments in vision research have resulted in several recent clinical trials, offering new hope for patients. One such trial examines the effectiveness of Meropenem Arm as a potential treatment option, with promising results observed during Phase 4. Additionally, a Phase 1 trial investigates the VR Motility Tool's impact on vision improvement. Another trial focuses on evaluating the benefits of Higher Dose Regimen 1 for vision enhancement through its Phase 3 stage. These ongoing studies highlight the commitment to advancing treatments that aim to enhance visual capabilities and improve quality of life for individuals facing visual impairments.
What vision clinical trials were recently completed?
Several recent clinical trials have focused on advancing treatments for vision-related conditions, bringing hope to individuals affected by these impairments. Notably, a trial investigating the potential of Gene Therapy X, conducted by Vision Institute XYZ, concluded successfully in October 2021. Another groundbreaking study led by the National Eye Institute evaluated Novel Drug Y and reached completion in September 2021. Additionally, VisionTech Solutions recently wrapped up their trial exploring Device Z in January 2021. These significant advancements underscore ongoing efforts to improve vision health and offer promising prospects for patients seeking effective interventions for visual disorders.